Bavarian U.S. Offices for Economic Development
80 Pine St., 24th Fl.
New York, NY 10005 USA
Our annual investor’s conference, OktoberINVESTfest, fosters innovation and transatlantic investment. To this end, we introduce financiers to a select group of high-quality American and German investment opportunities. This year’s event will focus on Cybersecurity, HealthTech, and Smart Factory/Smart City.
Welcome and Opening Remarks
Drivers of Innovation in Enterprise and Manufacturing Technology
Dikla Wagner – Head of Tech Scouting in Israel, Munich RE
Lyron Bentovim – President and CEO, The Glimpse Group
Jason Sydow – Partner, Next47 (Siemens VC)
Bill Kenney – Founder & Client Advocate, MEET (Moderator)
iHealthScreen | Cervity | Curbhub | Avlino Inc. | ITC.city | Protiec | Pomicell
Changes in the Way Innovation is Financed in the US, Germany, and Israel
Kiana Mardi – Founding Partner at Lucy Capital
Oren Sherf – Head of VC/PE Investments, Meitav Dash
Brian Keane – CEO, Qualified Capital, Family Office
Jonathan Glick – Technology Advisor, Bavarian Ministry of Economy, Israel Office (Moderator)
Litmus Automation | VitaScale | L7 Defense | SURAG Medical | Novel Microdevices Inc. | Munevo
End of Conference
Jason Sydow is venture capitalist based in Palo Alto, CA with Next47. He focuses on investments in application and infrastructure software, advanced manufacturing, and industrial technologies. Specific areas of interest include cyber security, industrial automation, additive manufacturing, industrial Internet of Things, and robotics. He has led investments in Bonsai.ai (acquired by MSFT), Identify3D, Riffyn, Falkonry, Citrine, and more.
Prior to joining Siemens, Jason was a Partner with QuestMark Partners, an expansion stage Venture Capital firm focused on Technology and Enterprise Software. Jason led investments in Enpirion (acquired by Altera), NComputing, and Guavus (acquired by Thales). He also served on the board of RF Code (holding acquired by Yet2 Ventures). Previously, Jason led licensing and new company formation for engineering and physical sciences in the tech transfer office of Arizona State University. Jason was the general manager for medical batteries at EaglePicher Technologies, an energy storage company. Initially, he worked 4 years at The Boston Consulting Group as a consultant and project leader.
Bill Kenney is a founder, convener, and connector. He has founded 8 companies. His current company, MEET (meetroi.com) helps international B2B growth companies soft land and scale quickly in the U.S. through trade shows and events. Bill also recently launched the Soft Land Partners (softlandpartners.com), a platform that connects market-entry companies with the “best fit” service providers to support their internationalization success. In the community, Bill mentors ventures globally. Bill engages audiences frequently with a relatable, actionable, and proven message that is changing business around the world. He speaks on a variety of topics, including U.S. market-entry, entrepreneurship, revenue generation, networking, and community building. Bill and his wife Kelly live on and operate their business from a sailboat.
Oren (CPA) began his career at BDO Israel in 2014, where he covered technology and real estate companies and was responsible for overseeing some of the largest IPOs on the TASE at that time. After qualifying as an accountant, Oren joined Arxcis Global Wealth Management, a prominent Israeli based family office, where he managed the alternative investments. Following Arxcis, Oren joined Meitav Dash, a leading Israeli institutional investor (AUM ~$50bn), as a portfolio manager in the alternative investments department. During the past two years, Oren has established the direct equity investments department, which manages the equity investments in emerging / venture technology companies. Notable investments to date include; UVeye, Nueroblade and BeeWise.
Brian D. Keane has over 20 years of Capital Markets and Investing experience. He specializes in originating, advising, and investing in emerging growth companies in the US, Canada, Caribbean and Asia. He has participated in over 100 investments, totaling over $2.5 Billion across every major industry.
Since 1999 he has advised and managed several investment funds and Investment Banks, that include: Paragon Capital, LP Keating Capital, Four Springs Capital, Yorkville Advisors, Merriman Capital, Inc, Rodman & Renshaw, LLC, (now HC Wainwright), Ladenburg Thalmann & Co. and Techvest LLC (acquired by Rodman). He began his career as an equity trader for NDB Group, NYSE:NDB (acquired by Deutsche Bank)
Currently, He is an advisor to Multiple Family Offices, Founder of Qualified Capital and 420 Acquisitions, LLC. He holds a BS from the University of Scranton 1997 and a JD from New York Law School 2000 and has held FINRA Series 7,55,63,79.
Kiana Mardi is Founding Partner at Lucy Capital, a VC that invests in mission-driven founders who build B2B technology companies that make the world more sustainable, inclusive, and healthy – from Pre-Seed to Series A. Previously Kiana was Investment Director for ALSTIN Capital and is member of various Boards.
Mr. Bentovim currently serves as The President and Chief Executive Officer of the Glimpse
Group, a Virtual Reality (VR) and Augmented Reality (AR) platform company (NASDAQ –
VRAR). Mr. Bentovim is a serial entrepreneur with 25+ years of leadership, operational and
Investment experience and he has led multiple public and private technology companies. Prior
To Founding The Glimpse Group, he served as Chief Operating Officer/Chief
Financial Officer of Top Image Systems (NASDAQ – TISA), Chief Operating Officer/Chief
Financial Officer of NIT Health and as the Chief Operating Officer and the Chief Financial
Officer of Sunrise Telecom, Inc.(NASDAQ – SRTI). Earlier is his career Mr. Bentovim was a
Managing Director and Portfolio Manager at Skiritai Capital LLC, an investment advisor based
in San Francisco and as the President & Chief Operating Officer and co-founder of WebBrix,
Inc. Additionally, Mr. Bentovim spent time with strategy consultancies USWeb/CKS, the
Mitchell Madison Group and McKinsey & Company Inc. Mr. Bentovim is a director at
Manhattan Bridge Capital (NASDAQ – LOAN) and has served on 9 public company boards and
numerous private company boards. He also serves as the Managing Partner of
DarkLight Partners, a strategic advisor to small and mid-size public and private companies. Mr.
Bentovim has an MBA from Yale School of Management and a law degree from the
Dikla leads tech scouting in Israel for Munich RE. MunichRe is the world’s largest reinsurance company, HQ in Munich, Germany, and is considered to be one of the pillars of the German economy. Dikla and her team scout for companies, technology, and opportunities that can transform MunichRE, clients and subsidiaries. She is a key opinion leader in #Insurtech topics (and beyond) covering Insurance tech, AI/Big Data, IoT, Cyber and Privacy, Mobility, Climate, as well as Digital Transformation. Since starting her career in the IDF Elite Intelligence Unit with 8200 units, Dikla has become an integral part of the tech/ entrepreneurship ecosystem for the past 15 years, as a VC investor, CEO of start-ups, and advisor for hundreds of start-ups. As a lawyer, she holds a Bachelor’s degree in Law and a Master’s in Business Administration.
Build and foster your network in business communities on three continents
From VCs, family offices, sector specific investors
Industry thought-leaders, and top-level management from presenting companies
Into how U.S., European, and Israeli VCs think about international expansion strategies for startups
From German, American, and Israeli Unicorns
From Invest in Bavaria, New York City, and Munich to open doors into all three regions
Looking to discover fast-growing US and European tech startups YOU are a company looking to expand your reach and networks in the US and GermanyApply To Attend
Seeking investment capital Get noticed and connect with investors, founders and thought leadersApply To Present
Vancouver, Canada | AI for Biopharma | Private
Our AI computational platform enables designing molecules for drug development faster than traditional methods, at a lower cost, and with a higher success rate. PROTEIC is developing a pipeline of targets including diseases that were historically considered undruggable. Our predictive models start by deriving insights from genetic, phenotypic, and clinical data, using machine learning to increase the power of traditional analyses moving us closer to the underlying architecture and biology of disease.
Boston, MA | Transportation & Logistics | Private
Curbhub offers lower-cost, sustainable same-day delivery services up to 100 miles, using a unique collaborative delivery model powered by a proprietary routing and scheduling technology. Our technology addresses operational inefficiencies of conventional modes of transportation and improves unit economics and fleet utilization by enabling transshipment to more efficient modes of transportation where and if needed. Overall, our services reduce, pollution, congestion, and safety incidents caused by the inefficiencies of delivery vehicles.
Munich, Germany | Medical Devices | Private
The Munevo GmbH team created Munevo DRIVE to provide an intuitive, comfortable electric wheelchair operation option for people with significant mobility impairments. Our mission is to empower people! Smartglasses transmit the user's head movements into digital signals, which enables them to operate their electric wheelchair hands-free. munevo DRIVE is compatible with various add-ons such as mobile devices, a robotic arm and smart home systems.
New Jersey | AI Software | Private
Avlino provides real-time AI Solutions to the Transportation and Logistics industries. Numerous global container terminal operators use Avlino's AI solutions to run their operations, and Avlino will be expanding into Vessel and Rail/Intermodal operations in 2022. From automation to autonomous intelligence, our approach combines patent-pending innovative technologies with an integrated process of Data Engineering, AI/ML, and domain-centric expertise. This method dramatically improves solution delivery, reducing implementation time and costs while increasing performance.
Ber Sheva, Israel | Cybersecurity | Private
Security for all data transactions online from OT to IOT. Ammune™, L7 Defense’s platform technology, protects services inline from the first request. It builds automatically a fully adapted protection layer to each and every service (API). APIs have become critical for data sharing and applications integration - as well as an attractive path for malicious attacks that expose organizations to new, continuously evolving threats. Ammune(TM) received in 2020 a Product Leadership Award by Frost & Sullivan, thanks to its novel unsupervised learning AI-based approach regarding applicative protection at the API resolution.
San Jose, CA | IoT | Private
Litmus is the only Industrial IoT Edge platform that unifies data collection and machine analytics with enterprise integration and application enablement. Litmus helps Fortune 500 companies harness the power of their industrial data for condition-based monitoring, predictive maintenance, machine learning and AI. With more device drivers than anyone in the industry plus pre-built machine analytics, integrations, and applications – Litmus simplifies how companies deploy Industrial IoT at scale.
Tel Aviv, Israel | Mobility | Private
ITC is an AI driven traffic management platform that proved it can prevent traffic jams by managing them right before they start to accumulate. Our cutting-edge computer vision algorithm uses off-the-shelf cameras to obtain live traffic data. Our algorithms accurately identify 99% of vehicles, as well as buses, ambulances, bikers and pedestrians. Using advanced machine learning and vast amounts of traffic data, we can tell exactly where and when traffic will start to overflow. By dynamically altering traffic light programming, we can adjust the traffic flow to mitigate congestion in advance.
Baltimore, MD | MedTech | Private
Novel Microdevices is a woman-owned, woman-led point-of-care infectious disease diagnostics company headquartered in Baltimore City, Maryland. Novel Microdevices is commercializing Novel Dx, a proprietary and best-in-class Point-of-Care (POC) rapid molecular diagnostics system that is ultra-portable, cloud-connected and can be produced for a wide range of high-volume molecular diagnostic assay applications. The company is focusing on women’s health and under-resourced populations in the $31 billion infectious diseases diagnostics market with tests in development for multiple respiratory and sexually transmitted infections.
Munich, Germany | RegTech | Private
Certivity is a RegTech software company developing a software platform to make regulatory management smarter, safer, more transparent, more efficient, and significantly cheaper. Certivity solve the problem of regulatory change management by enabling customers to model digital regulatory twins of their products. The regulatory twin can be integrated in the engineering process, while at the same time ensuring that the regular updates of regulations are considered. This enables unprecedented traceability into business processes.
Jerusalem, Israel | MedTech | Private
Pomicell is an expert validated SAAS platform for pharma companies. Our platform is taking all the scientific literature and relevant databases and through natural language processing (NLP) and machine learning creating an interactive model to accelerate pharma R&D. We utilize AI to create virtual molecular models of real-life patients and various types of drugs and diseases, in order to simulate personalized drug reactions and accurately predict patient-to-treatment compatibility.
New York, NY | Healthcare | Private
iHealthScreen (iHS) Inc. has CE certified product iPredict, an AI and telemedicine-based HIPAA compliant software tool for automated screening and prediction of individuals at risk of developing late age-related macular degeneration (AMD), diabetic retinopathy (DR), glaucoma. The company also developed and validated AI based prediction tool for Cardiovascular Heart Disease and stroke. The company now working for FDA clearance of these tools.
Magdeburg, Germany | MedTech | Private
SURAG develops guiding systems that allow surgeons to conduct minimally invasive procedures more precise, safe and, thus, efficient/ profitable. Our system helps to avoid complications and save costs for the clinics and the healthcare system. We do that using a completely new technology in medicine - acoustic emissions. We address a so far unmet clinical need of the minimally invasive laparoscopic and robot-assisted surgery: the absence of haptic and tactile information and navigation-related, supplementary feedback during surgery.
Nuremberg, Germany | Lifestyle, Medical, Automotive | Private
VitaScaleTM is a patented modular technological in respiratory gas analysis for precise non-invasive diagnostics & coaching, enabling precise & individual health status evaluation in real time for mega markets such as automotive, medicine & lifestyle. Hosted by the International Trade Council, the Startup won first place in the Go Global Awards 2021 in the Health Tech division! "Healthy employees are the engine and performance factor of long-term thinking companies. Smart devices can not only measure performance but also improve it through intelligent coaching functions" - Ulrich Jerichow
Are you looking to expand your company to Europe? We provide you with all the important information, valuable contacts and customized support for your expansion project. Our cross cultural teams in the U.S. and Bavaria, Germany look forward to helping you. Our services are always cost free and confidential.
Bavarian US Offices for
80 Pine St., 24th Fl. New York, NY 10005
Bavarian US Offices for
80 Pine St., 24th Fl. New York, NY 10005
OktoberINVESTfest is hosted by Invest in Bavaria, the investment promotion agency of Germany’s largest, most innovative state – Bavaria. Bavaria is a top-tier region in Europe and the center of German innovation. It’s capital Munich, as rated by the European Commission, is Europe’s #1 tech hub!
The Bavarian U.S. Offices for Economic Development are the U.S. representative offices for Invest in Bavaria, a division of the German State of Bavaria’s Ministry of Economic Affairs. We assist companies worldwide in expanding to Germany’s economic powerhouse, the State of Bavaria and vice-versa. With cross cultural teams in New York and San Francisco, we are part of Invest in Bavaria’s 25 offices around the world.
Bavarian U.S. Offices for Economic Development
80 Pine St., 24th Fl.
New York, NY 10005 USA